Nimble Science Ltd.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Holding
- Established
- 2018-03-13
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nimblesci.com
Clinical Trials
8
Active:2
Completed:1
Trial Phases
2 Phases
Phase 1:2
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (66.7%)Phase 1
2 (33.3%)Assessing Gut Microbiome Changes Before and After an Oral Nutritional Supplement Intake Using the SIMBA Capsule in Diabetic Participants
Phase 1
Not yet recruiting
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06704022
- Locations
- 🇨🇦
Nimble Science, Calgary, Alberta, Canada
Assessing the Safety of an IGY Supplement on the Gut Microbiome
Phase 1
Not yet recruiting
- Conditions
- HealthyMicrobiome
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT06702280
- Locations
- 🇨🇦
Nimble Science, Calgary, Alberta, Canada
The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule
Not Applicable
Active, not recruiting
- Conditions
- Amino Acid ChangeMicrotiaFood ScienceNutritionDigestion Rate
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT06394687
- Locations
- 🇨🇦
Cumming School of Medicine, Calgary, Alberta, Canada
The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms
Not Applicable
Recruiting
- Conditions
- SIBOSmall Intestinal Bacterial Overgrowth
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 105
- Registration Number
- NCT06317441
- Locations
- 🇨🇦
Nimble Science, Calgary, Alberta, Canada
Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease
Active, not recruiting
- Conditions
- Parkinson Disease
- Interventions
- Device: Fluid biopsy capsuleDrug: Levodopa-Carbidopa Immediate Release
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Nimble Science Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06003608
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
- Prev
- 1
- 2
- Next
News
No news found